Novel antagonist implicates the CB 1 cannabinoid receptor in the hypotensive action of anandamide

Author： Varga K. Lake K. Martin B.R. Kunos G.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.278, Iss.3, 1995-05, pp. : 279-283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CB1 – Cannabinoid Receptor Antagonist Effects on Cortisol in Cannabis-Dependent Men

By Goodwin Robert S. Baumann Michael H. Gorelick David A. Schwilke Eugene Schwope David M. Darwin William D. Kelly Deanna L. Schroeder Jennifer R. Ortemann-Renon Catherine Bonnet Denis Huestis Marilyn A.

The American Journal of Drug and Alcohol Abuse, Vol. 38, Iss. 1, 2012-01 ,pp. : 114-119

Informa Healthcare

Access to resources Recommend Favorite

Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity?

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. : 2141-2144

Informa Healthcare

Access to resources Recommend Favorite

Discriminative stimulus effects of the cannabinoid CB₁ receptor antagonist rimonabant in rats

By Järbe Torbjörn Li Chen Vadivel Subramanian Makriyannis Alexandros

Psychopharmacology, Vol. 198, Iss. 4, 2008-07 ,pp. : 467-478

Springer Publishing Company

Access to resources Recommend Favorite

CB1 Cannabinoid Receptor Ligands

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 7, 2005-07 ,pp. : 631-640

Bentham Science Publishers

Access to resources Recommend Favorite

The cannabinoid CB 1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2

By Darmani N.A.

European Journal of Pharmacology, Vol. 430, Iss. 1, 2001-10 ,pp. : 49-58

Elsevier

Access to resources Recommend Favorite